DeutschNewstral
Article
Bbarrons.com on 2020-01-27 17:22
Buy Biogen Now Because Its Alzheimer Drug Has a ‘Decent Shot’ at Approval
Related news
- BBiogen Is Spiking Because Its Alzheimer’s Drug Takes Another Step Toward Approvalbarrons.com
- BBuy Biogen Stock, Says Morgan Stanley, Because the Time Is Rightbarrons.com
- IBiogen skyrockets after Alzheimer’s drug approval – time to buy?invezz.com
- BBiogen Is Up After an Alzheimer-Drug Presentationbarrons.com
- BBiogen Stock Is Falling Because Earnings Guidance Came Up Shortbarrons.com
Biogen/Samsung Approval of BYOOVIZ™jdsupra.com- BBiogen Sold $1.6M of Aduhelm in Weeks After Approval. Earnings Were Strong.2 min readbarrons.com
- MRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug success as shares soar2 min readmarketwatch.com
- BAfter Lengthy Delay, Biogen Submits Troubled Alzheimer’s Drug for FDA Approvalbarrons.com
- FBiogen shares fall on Alzheimer trial resultsft.com
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com
- BBiogen Stock Jumps on FDA Approvalbarrons.com
- FBiogen to seek Alzheimer’s drug approvalft.com
Kehrtwende bei Alzheimer-Mittel - Biogen beantragt US-ZulassungReuters- MÄRKTE-Biogen heben ab nach Studienerfolg von Alzheimer-MittelReuters
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’The Japan Times- WAlzheimer's drug from Biogen, partner receives FDA approvalwraltechwire.com
House investigation faults FDA, Biogen for Alzheimer’s drug approvalpost-gazette.com
BiogenForbes
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approvalobserver.com